Skip to main content
. 2022 May 21;67:116838. doi: 10.1016/j.bmc.2022.116838

Fig. 5.

Fig. 5

Docking results of compounds 9a and 9r in the active sites of SARS-CoV-2 spike RBD (PDB: 6M0J) and human ACE2 proteins (PDB: 3AXH). (A) and (B) Predicted interactions of compounds 9a and 9r with SARS-CoV-2 spike RBD, respectively. (C) and (D) Predicted interactions of compounds 9a and 9r with human ACE2 protein, respectively.